General Information of the Compound
| Compound ID |
CP0463916
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CHEBI:4888
Show/Hide
|
||||||||||||||||||
| Synonyms |
(+-)-3-Ethyl-5-phenylhydantoin
1-Ethyl-2,5-dioxo-4-phenylimidazolidine
3-Ethyl-5-phenyl-2,4-imidazolidinedione
3-Ethyl-5-phenylhydantoin
3-Ethyl-5-phenylimidazolidin-2,4-dione
3-ethyl-5-phenylimidazolidine-2,4-dione
Abbott brand of ethotoin
Accenon
Accenon (TN)
Ethotoin
Ethotoin (JAN/USP/INN)
Ethotoin [INN:BAN:JAN]
Ethotoine
Ethotoine [INN-French]
Ethotoinum
Ethotoinum [INN-Latin]
Etotoina
Etotoina [INN-Spanish]
Peganone
Peganone (TN)
Pegoanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H12N2O2
|
||||||||||||||||||
| Molecular Weight |
204.229
|
||||||||||||||||||
| Canonical SMILES |
CCN1C(=O)NC(C1=O)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SZQIFWWUIBRPBZ-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
86-35-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound